Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Coron Artery Dis ; 33(6): 473-478, 2022 09 01.
Article in English | MEDLINE | ID: mdl-35500098

ABSTRACT

OBJECTIVE: The study aimed to explore the effect of different doses of atorvastatin on collateral formation in coronary artery disease (CAD) patients with coronary atherosclerosis. METHODS: The study included 218 CAD patients who received treatment between January 2017 and January 2020 at our hospital. They were assigned to the high-dose group (40 mg atorvastatin) and the low-dose group (20 mg atorvastatin) using the random table method with 109 patients per group. The blood lipid levels, TNF-α, hs-CRP, NO, and coronary atherosclerosis collateral formation before and after treatment in the two groups were compared, and favorable factors of good coronary artery collateral circulation were analyzed by multivariate logistic regression analysis. RESULTS: LDL-C, TG, and TC levels decreased, whereas HDL-C levels increased in the two groups after treatment. The high-dose group had lower LDL-C, TG, and TC levels but higher HDL-C levels than the low-dose group, and the difference was statistically significant ( P < 0.05). TNF-α and hs-CRP levels decreased while NO levels increased in both groups after treatment. The high-dose group had lower TNF-α and hs-CRP levels but higher NO levels than the low-dose group, and the difference was statistically significant ( P < 0.05). CONCLUSION: High-dose atorvastatin could blood lipid levels of modulate CAD patients and promote coronary atherosclerosis collateral formation. In addition, hypertension, LDL-C, HDL-C, TNF-α, hs-CRP, and NO were independent determinants of good coronary artery collateral circulation.


Subject(s)
Atherosclerosis , Coronary Artery Disease , Atorvastatin , C-Reactive Protein , Cholesterol, LDL , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/drug therapy , Humans , Lipids , Tumor Necrosis Factor-alpha
2.
Chin J Integr Med ; 19(7): 505-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23818202

ABSTRACT

OBJECTIVE: To investigate the effects of clearing the Governor Vessel and refreshing the mind needling in neural development and remediation of children with cerebral palsy. METHODS: A total of 200 cases of children with cerebral palsy were randomly assigned to the treatment group (100 patients) and the control group (100 patients). The treatment group was given the combined therapy of acupuncture and rehabilitation training, and the chosen acupoints were 13 points of the Governor Vessel, Shenshu (BL 23), Taixi (KI 3), Yanglingquan (GB 34), Zusanli (ST 36) and Sanyinjiao (SP 6), and points of refreshing the mind were also selected, which included puncturing Shenting (GV 24) toward Qianding (GV 21), puncturing Qianding (GV 21) toward Baihui (GV 20), puncturing Baihui (GV 20) toward Naohu (GV 17) and Sishencong (Ex-HN 1). The control group was only treated with rehabilitation training. A contrastive analysis of the therapeutic effect between acupuncture combined with rehabilitation training and rehabilitation training alone was made after a treatment course of 3 months. The Gross Motor Function Measure (GMFM) and Beijing Gesell Developmental Scale were adopted to assess the neural development and rehabilitation outcomes of the two groups. In addition, skull CT/MRI was adopted to evaluate the plerosis of injured cerebral nerve after treatment. RESULTS: The total effective rate in treatment group was 87% (87/100), significantly higher than the 55% (55/100) in the control group. The children's development quotient (DQ) tested by Gesell Developmental Scale and scores tested by GMFM in the treatment group were obviously higher than those in the control group (P<0.01). The improving and curing rates presented by skull CT/MRI in the treatment group were higher than those in the control group (P<0.01). CONCLUSIONS: Clearing the Governor Vessel and refreshing the mind needling could accelerate the recovery of injured brain nerve and the reconstruction of brain function. The acupuncture therapy could ameliorate both the motor development and cognitive development. On the other hand, the forward curative effect of acupuncture combined with rehabilitation training was significantly better than the rehabilitation training alone.


Subject(s)
Acupuncture Points , Acupuncture Therapy , Cerebral Palsy/therapy , Nervous System/growth & development , Acupuncture Therapy/adverse effects , Cerebral Palsy/diagnostic imaging , Cerebral Palsy/rehabilitation , Child , Child, Preschool , Female , Humans , Infant , Magnetic Resonance Imaging , Male , Skull/diagnostic imaging , Tomography, X-Ray Computed , Treatment Outcome
3.
Zhongguo Zhen Jiu ; 27(8): 565-8, 2007 Aug.
Article in Chinese | MEDLINE | ID: mdl-17853751

ABSTRACT

OBJECTIVE: To investigate the compensation of cerebral function in acupuncture for rehabilitation of cerebral palsy. METHODS: One hundred children of cerebral palsy were randomly divided into a treatment group and a control group, 50 cases in each group. The treatment group were treated with scalp acupuncture at the Motor Area, Foot Motor Sensory Area and Equilibrium Area, body acupuncture at Binao (LI 14), Fengchi (GB 20), Huantiao (GB 30), etc. and injection of nerve growth factor into Zusanli (ST 36), in combination with rehabilitation training; the control group were treated only with rehabilitation training. Their clinical therapeutic effects and recoveries of brain lesion detected by CT, SEPCT were investigated. RESULTS: The total effective rate was 84.0% in the treatment group better than 52.0% of the control group. After treatment, the development quotient (DQ) in the treatment group was higher than the control group (P<0.01). CONCLUSION: Acupuncture can promote compensation of cerebral function in the children of cerebral palsy.


Subject(s)
Acupuncture Therapy/methods , Brain/physiopathology , Cerebral Palsy/therapy , Moxibustion/methods , Nerve Growth Factor/therapeutic use , Acupuncture Points , Cerebral Palsy/physiopathology , Cerebrovascular Circulation , Child , Child, Preschool , Humans , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed
4.
Zhong Yao Cai ; 30(3): 377-80, 2007 Mar.
Article in Chinese | MEDLINE | ID: mdl-17634051

ABSTRACT

OBJECTIVE: To investigate the repairing mechanism of Fuzheng Peiben Therapy on cellular immunofunction in patients with breast cancer on cellar and molecular level. METHODS: The tumor tissue and axillary lymph node samples were evaluated with the flow cytometry for CD83, CD80, CD86 before and after neoadujvant therapy. RESULTS: The levels of CD83, CD80, CD86 were singificantly decreased in group A (treated with surgery only), B (treated with neoadujvant chemotherapy plus surgery) and C (treated with neoadujvant chemotherapy plus surgery with shenqi Fuzheng Injection) compared with that in normal team (P < 0.05 or 0.01); The levels of CD83, CD80, CD86 were significantly decreased in group A, B and C compared between before and after neoadujvant chemotherapy (P < 0.05 or 0.01); They were not significantly decreased between group A and group C (P > 0.05). CONCLUSION: The cellular immunity was inpaired considerably by neoadujvant chemotherapy. Neoadjuvant chemotherapy combined with Shenqi Fuzheng Injection can enhance the cellular immunity considerably.


Subject(s)
Breast Neoplasms/drug therapy , Dendritic Cells/drug effects , Drugs, Chinese Herbal/chemistry , Immunity, Cellular/drug effects , Breast Neoplasms/immunology , Dendritic Cells/immunology , Humans
5.
Chin J Integr Med ; 13(1): 37-40, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17578316

ABSTRACT

OBJECTIVE: To study the effect of Shenqi Fuzheng Injection (SFI) on cellular immune in patients with mammary cancer (MC) after chemotherapy. METHODS: One hundred and ten patients with MC were randomly assigned to two groups. The 58 patients in the tested group were treated with SFI in cooperation with chemotherapy of CAF protocol (Cyclophosphamide, Doxorubicin and Fluorouracil), while the 52 patients in the control group were treated with chemotherapy of the same protocol alone. Changes of the patients' quality of life (QOF), adverse reaction that occurred, peripheral lymphocyte count and killing activity of single karyocyte before and after treatment between the two groups were compared. RESULTS: Patients' QOF elevating rate after treatment in the tested group and the control group was 34.5% and 13.5% respectively; The lowering of peripheral blood cell count of WBC, platelet and lymphocyte as well as that of the killing activity of single peripheral karyocyte on various kinds of MC cells were all milder and recovery sooner than those in the control group. CONCLUSION: SFI in combination with chemotherapy in treating MC could reduce the occurrence of adverse reaction to chemotherapy, improve clinical symptoms, elevate QOF and enhance immunity in patients with MC.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/therapy , Carcinoma, Ductal, Breast/immunology , Carcinoma, Ductal, Breast/therapy , Drugs, Chinese Herbal/administration & dosage , Immunity, Cellular/drug effects , Adult , Aged , Blood Cell Count , Breast Neoplasms/blood , Breast Neoplasms/physiopathology , Carcinoma, Ductal, Breast/blood , Carcinoma, Ductal, Breast/physiopathology , Cell Death , Complementary Therapies , Cyclophosphamide/therapeutic use , Doxorubicin/therapeutic use , Drugs, Chinese Herbal/adverse effects , Drugs, Chinese Herbal/therapeutic use , Female , Fluorouracil/therapeutic use , Humans , Injections , Lymphocyte Subsets/pathology , Middle Aged , Monocytes/immunology , Quality of Life
SELECTION OF CITATIONS
SEARCH DETAIL